Indomethacin induced gene regulation in the rat hippocampus

Monica Sathyanesan, Matthew J. Girgenti, Jennifer Warner-Schmidt, Samuel S. Newton

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Non-steroidal anti-inflammatory drugs such as indomethacin are widely used to treat inflammatory diseases and manage pain, fever and inflammation in several conditions, including neuropsychiatric disorders. Although they predominantly function by inhibiting cyclooxygenase (COX) activity, important COX-independent actions also occur. These actions could be responsible for the adverse side effects associated with chronic and/or high dose usage of this popular drug class. Results: We examined gene regulation in the hippocampus after peripheral administration of indomethacin by employing a microarray approach. Secondary confirmation and the brain expression pattern of regulated genes was examined by in situ hybridization and immunohistochemistry. Transglutaminase 2, serum glucocorticoid inducible kinase, Inhibitor of NF-kappa B and vascular endothelial growth factor were among genes that were prominently upregulated, while G-protein coupled receptor 56 and neuropeptide Y were among genes that were downregulated by indomethacin. Co-localization studies using blood vessel markers revealed that transglutaminase 2 was induced specifically in brain vasculature. Conclusions: The data demonstrate that COX-inhibitors can differentially regulate gene transcription in multiple, functionally distinctly cell types in the brain. The results provide additional insight into the molecular actions of COX-inhibitors and indicate that their effects on vasculature could influence cerebral blood flow mechanisms.

Original languageEnglish (US)
Article number59
JournalMolecular Brain
Volume8
Issue number1
DOIs
StatePublished - Oct 6 2015

Fingerprint

Indomethacin
Hippocampus
Cyclooxygenase Inhibitors
Genes
Prostaglandin-Endoperoxide Synthases
Cerebrovascular Circulation
Brain
NF-kappa B
Neuropeptide Y
G-Protein-Coupled Receptors
Pharmaceutical Preparations
Vascular Endothelial Growth Factor A
Glucocorticoids
In Situ Hybridization
Blood Vessels
Anti-Inflammatory Agents
Fever
Down-Regulation
Immunohistochemistry
Inflammation

Keywords

  • Cerebrovascular
  • Cyclooxygenase inhibitor
  • Gene expression
  • Hippocampus
  • NSAID

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Indomethacin induced gene regulation in the rat hippocampus. / Sathyanesan, Monica; Girgenti, Matthew J.; Warner-Schmidt, Jennifer; Newton, Samuel S.

In: Molecular Brain, Vol. 8, No. 1, 59, 06.10.2015.

Research output: Contribution to journalArticle

Sathyanesan, Monica ; Girgenti, Matthew J. ; Warner-Schmidt, Jennifer ; Newton, Samuel S. / Indomethacin induced gene regulation in the rat hippocampus. In: Molecular Brain. 2015 ; Vol. 8, No. 1.
@article{afca507c62c342638cc81db83b088b50,
title = "Indomethacin induced gene regulation in the rat hippocampus",
abstract = "Background: Non-steroidal anti-inflammatory drugs such as indomethacin are widely used to treat inflammatory diseases and manage pain, fever and inflammation in several conditions, including neuropsychiatric disorders. Although they predominantly function by inhibiting cyclooxygenase (COX) activity, important COX-independent actions also occur. These actions could be responsible for the adverse side effects associated with chronic and/or high dose usage of this popular drug class. Results: We examined gene regulation in the hippocampus after peripheral administration of indomethacin by employing a microarray approach. Secondary confirmation and the brain expression pattern of regulated genes was examined by in situ hybridization and immunohistochemistry. Transglutaminase 2, serum glucocorticoid inducible kinase, Inhibitor of NF-kappa B and vascular endothelial growth factor were among genes that were prominently upregulated, while G-protein coupled receptor 56 and neuropeptide Y were among genes that were downregulated by indomethacin. Co-localization studies using blood vessel markers revealed that transglutaminase 2 was induced specifically in brain vasculature. Conclusions: The data demonstrate that COX-inhibitors can differentially regulate gene transcription in multiple, functionally distinctly cell types in the brain. The results provide additional insight into the molecular actions of COX-inhibitors and indicate that their effects on vasculature could influence cerebral blood flow mechanisms.",
keywords = "Cerebrovascular, Cyclooxygenase inhibitor, Gene expression, Hippocampus, NSAID",
author = "Monica Sathyanesan and Girgenti, {Matthew J.} and Jennifer Warner-Schmidt and Newton, {Samuel S.}",
year = "2015",
month = "10",
day = "6",
doi = "10.1186/s13041-015-0150-x",
language = "English (US)",
volume = "8",
journal = "Molecular Brain",
issn = "1756-6606",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Indomethacin induced gene regulation in the rat hippocampus

AU - Sathyanesan, Monica

AU - Girgenti, Matthew J.

AU - Warner-Schmidt, Jennifer

AU - Newton, Samuel S.

PY - 2015/10/6

Y1 - 2015/10/6

N2 - Background: Non-steroidal anti-inflammatory drugs such as indomethacin are widely used to treat inflammatory diseases and manage pain, fever and inflammation in several conditions, including neuropsychiatric disorders. Although they predominantly function by inhibiting cyclooxygenase (COX) activity, important COX-independent actions also occur. These actions could be responsible for the adverse side effects associated with chronic and/or high dose usage of this popular drug class. Results: We examined gene regulation in the hippocampus after peripheral administration of indomethacin by employing a microarray approach. Secondary confirmation and the brain expression pattern of regulated genes was examined by in situ hybridization and immunohistochemistry. Transglutaminase 2, serum glucocorticoid inducible kinase, Inhibitor of NF-kappa B and vascular endothelial growth factor were among genes that were prominently upregulated, while G-protein coupled receptor 56 and neuropeptide Y were among genes that were downregulated by indomethacin. Co-localization studies using blood vessel markers revealed that transglutaminase 2 was induced specifically in brain vasculature. Conclusions: The data demonstrate that COX-inhibitors can differentially regulate gene transcription in multiple, functionally distinctly cell types in the brain. The results provide additional insight into the molecular actions of COX-inhibitors and indicate that their effects on vasculature could influence cerebral blood flow mechanisms.

AB - Background: Non-steroidal anti-inflammatory drugs such as indomethacin are widely used to treat inflammatory diseases and manage pain, fever and inflammation in several conditions, including neuropsychiatric disorders. Although they predominantly function by inhibiting cyclooxygenase (COX) activity, important COX-independent actions also occur. These actions could be responsible for the adverse side effects associated with chronic and/or high dose usage of this popular drug class. Results: We examined gene regulation in the hippocampus after peripheral administration of indomethacin by employing a microarray approach. Secondary confirmation and the brain expression pattern of regulated genes was examined by in situ hybridization and immunohistochemistry. Transglutaminase 2, serum glucocorticoid inducible kinase, Inhibitor of NF-kappa B and vascular endothelial growth factor were among genes that were prominently upregulated, while G-protein coupled receptor 56 and neuropeptide Y were among genes that were downregulated by indomethacin. Co-localization studies using blood vessel markers revealed that transglutaminase 2 was induced specifically in brain vasculature. Conclusions: The data demonstrate that COX-inhibitors can differentially regulate gene transcription in multiple, functionally distinctly cell types in the brain. The results provide additional insight into the molecular actions of COX-inhibitors and indicate that their effects on vasculature could influence cerebral blood flow mechanisms.

KW - Cerebrovascular

KW - Cyclooxygenase inhibitor

KW - Gene expression

KW - Hippocampus

KW - NSAID

UR - http://www.scopus.com/inward/record.url?scp=84943586584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943586584&partnerID=8YFLogxK

U2 - 10.1186/s13041-015-0150-x

DO - 10.1186/s13041-015-0150-x

M3 - Article

C2 - 26438564

AN - SCOPUS:84943586584

VL - 8

JO - Molecular Brain

JF - Molecular Brain

SN - 1756-6606

IS - 1

M1 - 59

ER -